Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Scharnagl Hubert |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Emrich, I; Trieb, M; Scharnagl, H; Pregartner, G; Holzer, M; Rogacev, K; Bohm, M; Heine, GH; Marsche, G HDL Subclasses as a Prognosis Marker of newly occurring cardiovascular Events in chronic Kidney Disease
INTERNIST. 2020; 61(SUPPL 1):S7-S8. [Oral Communication]
Web of Science

 

Aberer, F; Pferschy, P; Tripolt, N; Sourij, C; Obermayer, AM; Pruller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H Hypoglycaemia leads to Platelet- and Coagulation Activation in Patients with Type 2 Diabetes under Metformin-Monotherapy - Results of hyperinsulinaemic hypoglycaemic Clamp-Study
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S461-S462. [Poster]
Web of Science

 

Aberer, F; Pferschy, PN; Tripolt, N; Sourij, C; Obermayer, AM; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H Hypoglykämie führt zu einer Plättchen- und Gerinnungsaktivierung bei PatientInnen mit Typ 2 Diabetes unter Metformin-Monotherapie – Ergebnisse einer hyperinsulinämischen hypoglykämischen Clamp-Studie
Freier Vortrag. 2019; 131 (Suppl5) : 461-462.-47. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2019; Salzburg . [Oral Communication]
FullText

 

Aberer, F; Pferschy PN; Tripolt, NJ; Sourij, C; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Riedl, R; Novak, E; Obermayer, AM; Reitbauer, P; Stojakovic, T; Scharnagl, H; Aziz, F; Oulhaj, A; Prüller, F; Sourij, H Hypoglycemia Leads to a Delayed Increase in Platelet and Coagulation Markers in Subjects with Type 2 Diabetes Treated with Metformin Only—Results from an Experimental Stepwise Hypoglycemic Clamp Study
Diabetes 2019 Jun; 68(Supplement 1). 2019; -78th Scientific Sessions of the American Diabetes Association (ADA); JUN 19-22, 2019 ; Orlando . [Poster]

 

Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C; Obermayer, A; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H Hypoglycaemia leads to delayed increase in platelet and coagulation activation markers in subjects with type 2 diabetes – results from a stepwise hypoglycaemic clamp study
Scientific Programme of the 5th CVOT Summit 2019. 2019; 28: 28-28.-CVOT Summit 2019; OCT 24-25, 2019; Munich, GERMANY. [Poster]
FullText

 

Aberer, F; Tripolt, N; Pferschy, P; Pruller, F; Riedl, R; Aziz, F; Obermayer, A; Kojzar, H; Stojakovic, T; Scharnagl, H; Oulhaj, A; Sourij, C; Brunner, M; Novak, E; Sourij, H Acute and prolonged effects of clamp-induced hypoglycaemia on procoagulatory markers in subjects with type 2 diabetes treated with metformin only
DIABETOLOGIA. 2019; 62: S417-S417. [Poster]
Web of Science

 

Herrmann, M; Pusceddu, I; Kleber, ME; Scharnagl, H; Marz, W; Herrmann, W SHORT TELOMERES, A COMMON RISK FACTOR OF ALL CAUSE AND CARDIOVASCULAR MORTALITY IN VITAMIN B- AND D-DEFICIENT SUBJECTS
ANTICANCER RES. 2019; 39(6):3279-3279. [Poster]
Web of Science

 

Hoch, D; Bachbauer, M; Pöchlauer, C; Novak, S; Majali-Martinez, A; Nonn, O; Forstner, D; Maninger, S; Scharnagl, H; Hauguel-de Mouzon, S; Glasner, A; Gauster, M; Desoye, G Obesity-associated DNA damage and its consequences for the early human cytotrophoblast
51st Annual Diabetic Pregnancy Study Group (DPSG) Meeting; SEP 5-7, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Kalsch, AI; Kleber, M; Sattler, W; Kramer, BK; Marz, W; Malle, E; Leipe, J; Scharnagl, H LONG- AND SHORT-TERM ASSOCIATION OF LOW-GRADE SYSTEMIC INFLAMMATION WITH CARDIOVASCULAR MORTALITY
J HYPERTENS. 2019; 37: E295-E295.-29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH); JUN 21-24, 2019; Milan, ITALY. [Oral Communication]
Web of Science FullText FullText_MUG

 

Kassner, U; Hollstein, T; Schumann, F; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E PROPROTEIN CONVERTASE SUBTILISIN/ KEXIN TYPE 9 ANTIBODIES (PCSK9-I) TREATMENT OF CARDIOVASCULAR HIGH RISK PATIENTS IN CLINICAL PRACTICE
ATHEROSCLEROSIS. 2019; 287: E212-E212.-87th Congress of the European-Atherosclerosis-Society (EAS); MAY 26-29, 2019; Maastricht, NETHERLANDS. [Poster]
Web of Science FullText FullText_MUG

 

Leipe, J; Kaelsch, AI; Kleber, M; Scharnagl, H; Sattler, W; Marz, W; Malle, E; Kraemer, B LONG- AND SHORT-TERM ASSOCIATION OF LOW-GRADE SYSTEMIC INFLAMMATION WITH CARDIOVASCULAR MORTALITY
ANN RHEUM DIS. 2019; 78: 1028-1028.-Annual European Congress of Rheumatology (EULAR); JUN 12-15, 2019; Madrid, SPAIN. [Oral Communication] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Remetic, J; Mlitz, V; Kunczer, V; Scharnagl, H; Stojakovic, T; Fuchs, CD; Trauner, MH LOSS OF BILE SALT EXPORT PUMP (BSEP/Abcb11) AGGRAVATES LIPOPOLYSACCHARIDE-INDUCED HEPATIC INFLAMMATION IN MICE
HEPATOLOGY. 2019; 70: 812A-813A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

Scheuer, AL; Emrich, IE; Rogacev, KS; Solovyeva, E; Scharnagl, H; Martin, SS; Fliser, D; Bohm, M; Marsche, G; Geisel, J; Heine, GH Comparison of Low-Density Lipoprotein Estimation by using the Friedewald Formula vs. Martin/Hopkins Formula in a Cohort of chronically kidney Patients
INTERNIST. 2019; 60: S35-S35. [Poster]
Web of Science

 

Silbernagel, G; Scharnagl, H; Kleber, ME; Hoffmann, MM; Delgado, G; Stojakovic, T; Gary, T; Zeng, L; Ritsch, A; Zewinger, S; Speer, T; Schunkert, H; Landmesser, U; Marz, W; Grammer, T COMMON APOC3 VARIANTS AND CORONARY ARTERY DISEASE
ATHEROSCLEROSIS. 2019; 287: E61-E62.-87th Congress of the European-Atherosclerosis-Society (EAS); MAY 26-29, 2019; Maastricht, NETHERLANDS. [Poster]
Web of Science FullText FullText_MUG

 

Zhu, C; Boucheron, N; Muller, A; Majek, P; Fuchs, C; Baazim, H; Lercher, A; Halilbasic, E; Gulich, A; Sakaguchi, S; Sandner, L; Stojakovic, T; Scharnagl, H; Bergthaler, A; Ellmeier, W; Trauner, M 24-nor-ursodeoxycholic acid ameliorates inflammation by reshaping mTOR proteome and immunometabolism sensing programs in CD8 T cells
EUR J IMMUNOL. 2019; 49: 1282-1282.-17th International Congress of Immunology (IUIS); OCT 19-23, 2019; Beijing, PEOPLES R CHINA. [Poster]
Web of Science

 

Aberer, F; Tripolt, NJ; Scharnagl, H; Zedler, J; Eder, M; Oulhaj, A; Stojakovic, T; Sourij, H COMBINED SERUM FREE LIGHT CHAIN LEVELS ARE ASSOCIATED WITH CAROTID ATHEROSCLEROSIS IN TYPE 2 DIABETES MELLITUS
ATHEROSCLEROSIS. 2018; 275: E247-E247.-86th Congress of the European-Atherosclerosis-Society (EAS); MAY 05-08, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science FullText FullText_MUG

 

Blom, W; Koppenol, W; Hiemstra, H; Stojakovic, T; Scharnagl, H; Trautwein, E A LOW-FAT SPREAD WITH ADDED PLANT STEROLS AND FISH OIL LOWERS SERUM TRIGLYCERIDE AND LDL-CHOLESTEROL CONCENTRATIONS IN INDIVIDUALS WITH MODEST HYPERCHOLESTEROLAEMIA AND HYPERTRIGLYCERIDAEMIA
ATHEROSCLEROSIS. 2018; 275: E153-E154.-86th Congress of the European-Atherosclerosis-Society (EAS); MAY 05-08, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science FullText FullText_MUG

 

Enko, D; Meinitzer, A; Schnedl WJ; Halwachs-Baumann G; Kriegshäuser G Assessment of serum lipid levels in patients with depressive disorder and healthy controls.
34th World Congress of Internal Medicine; OKT 18-21, 2018; Cape Town, SOUTH AFRICA. 2018. [Poster]

 

Fuchs, CD; Krivanec, S; Steinacher, D; Wahlstrom, A; Stahlman, M; Claudel, T; Scharnagl, H; Stojakovic, T; Marschall, HU; Trauner, MH Absence of Bsep Attenuates Mcd Diet Induced Hepatic Steatosis but Aggravates Inflammation in Mice
HEPATOLOGY. 2018; 68: 1003A-1004A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

Hoch D., Bandres J., Bachbauer M., Poechlauer C., Majali-Martinez A., Nonn O., Forstner D., Maninger S., Scharnagl H., Hauguel-de Mouzon S., Gauster M., Desoye G. Obesity-associated DNA damage and its consequences for the early human cytotrophoblast
Annual Doctoral Day at the Medical University of Graz 2018; NOV 28 2018; Graz, AUSTRIA. 2018. [Poster]
FullText

 

Hollstein, T; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E; Kassner, U PCSK9-inhibitor treatment of cardiovascular high risk patients in clinical practice - new data regarding safety and effectivity
INTERNIST. 2018; 59: S11-S12. [Poster]
Web of Science

 

Hollstein, T; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E; Kassner, U PCSK9-INHIBITOR TREATMENT OF CARDIOVASCULAR HIGH RISK PATIENTS IN CLINICAL PRACTICE - NEW DATA REGARDING SAFETY AND EFFECTIVITY
ATHEROSCLEROSIS. 2018; 275: E31-E31.-86th Congress of the European-Atherosclerosis-Society (EAS); MAY 05-08, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science FullText FullText_MUG

 

Ritsch, A; Duerr, A; Kahler, P; Hunjadi, M; Stojakovic, T; Zewinger, S; Speer, T; Silbernagl, G; Scharnagl, H; Kleber, M; Marz, W INDEPENDENT EFFECTS OF KIDNEY FUNCTION AND CHOLERSTEROL EFFLUX ON CARDIOVASCULAR MORTALITY
ATHEROSCLEROSIS. 2018; 275: E28-E28.-86th Congress of the European-Atherosclerosis-Society (EAS); MAY 05-08, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science FullText FullText_MUG

 

Schmid, J; Birner-Gruenberger, R; Liesinger, L; Stojakovic, T; Scharnagl, H; Dieplinger, B; Asslaber, M; Quasthoff, S; Binder, JS; Rainer, PP Elevated measured cardiac troponin T in skeletal myopathies - Re-expression in skeletal muscle or assay cross-reaction?
Frontiers in CardioVascular Biology; APR 20-22; Vienna, Austria. 2018. [Poster]

 

Werner, C; Stojakovic, T; Speer, T; Zewinger, S; Maerz, W; Scharnagl, H; Laufs, U Apolipoprotein C-III concentrations in chylomicron-free serum predict cardiovascular outcomes in patients with coronary artery disease
EUR HEART J. 2018; 39: 753-753.-European-Society-of-Cardiology Congress; AUG 25-29, 2018; Munich, GERMANY. [Poster]
Web of Science

 

Aberer, F; Tripolt, NJ; Eder, M; Scharnagl, H; Stojakovic, T; Sourij, H Polyclonal serum free light chains levels are associated with carotid atherosclerosis in subjects with type 2 diabetes mellitus
Abstract Volume, Human health: From laboratory models to clinical studies. 2017; 42-42.-6th International Symposium of the Human Nutrition & Metabolism Research and Training Center (HNMRC); Sep 16, 2017; Graz. (ISBN: 978-3-200-05266-6 ) [Poster]

 

Aberer, F; Tripolt, NJ; Eder, M; Scharnagl, H; Stojakovic, T; Sourij, H Polyclonal serum free light chain levels are associated with carotid arterosclerosis in subjects with type 2 diabetes mellitus
Diabetes. 2017; 66(S1):A117-A117.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Poster]

 

Baumstark, D; Neumann, S; Eiglsperger, J; Norkauer, S; Wieczorek, J; Fuhrmann, M; Mundner, M; Wack, J; Scharnagl, H; Stojakovic, T; Marz, W; Pagel, P LIPOPROTEIN PROFILING WITH THE AXINON (R) SYSTEM
ATHEROSCLEROSIS. 2017; 263: E201-E201.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. [Poster]
Web of Science FullText FullText_MUG

 

Schmid, J; Birner-Gruenberger, R; Liesinger, L; Stojakovic, T; Scharnagl, H; Dieplinger, B; Asslaber, M; Radl, R; Polacin, M; Beer, M; Szolar, F; Quasthoff, S; Binder, JS; Rainer, P Elevated cardiac troponin T but not troponin I in patients with skeletal muscle disease
European Heart Journal, Vol 38, Issue suppl 1, 1 Aug 2017, ehx502.P2612,. 2017; -ESC Congress; AUG 26-30; Barcelona, Spain. [Poster]
FullText

 

Schmid, J; Stojakovic, T; Zweiker, D; Scharnagl, H; Maderthaner, RD; Scherr, D; Maier, R; Schmidt, A; März, W; Binder, JS; Rainer, PP Comparison of Novel Biomarkers ST2, Galectin 3 and FGF23 for Prediction of Survival in Patients Undergoing Transcatheter Aortic Valve Implantation
CardioFlame Symposium; NOV 23-24, 2017; Graz, AUSTRIA. 2017. [Poster]

 

Schmid, J; Zweiker, D; Stojakovic, T; Scharnagl, H; Maderthaner, R; Scherr, D; Maier, R; Schmidt, A; März, W; Binder, J; Rainer, P ST2 predicts survival in patients undergoing transcatheter aortic valve implantation
WIEN KLIN WOCHENSCHR. 2017; 129 (Suppl 1): S102. 2017; -ÖKG Jahrestagung; JUN 7-10, 2017; Salzburg, AUSTRIA. [Poster]

 

Silbernagel, G; Scharnagl, H; Kleber, M; Stojakovic, T; März W CIRCULATING PCSK9 IS NOT ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY
Journal of the American College of Cardiology WOS:000397342302384 . 2017; 69(9):1662-1662.-ACC.17: 66th Annual Scientific Session & Expo; Mar 17-19, 2017; Washinton, United States. [Oral Communication]
Web of Science

 

Silbernagel, G; Scharnagl, H; Kleber, ME; Grammer, TB; Delgado, G; Stojakovic, T; Gary, T; Ritsch, A; Zewinger, S; Speer, T; Landmesser, U; Marz, W J-SHAPED ASSOCIATION OF CIRCULATING APOLIPOPROTEIN C3 WITH CARDIOVASCULAR MORTALITY
ATHEROSCLEROSIS. 2017; 263: E89-E90.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. [Oral Communication]
Web of Science FullText FullText_MUG

 

Steinacher, D; Claudel, T; Griessner, J; Einwallner, E; Ruhlemann, MC; Ronda, O; Heinsen, FA; Stojakovic, T; Scharnagl, H; Verkade, HJ; Haubensak, WE; Trauner, M NorUDCA improves liver injury and metabolic situation in mouse models of obesity and steatosis
J HEPATOL. 2017; 66(1):S168-S168.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. [Poster]
Web of Science FullText FullText_MUG

 

Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science FullText

 

Voortman, MM; Pekar, T; Bachmayer D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
Neurologisch. 2017; 2017(S2):50-51.-14. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Mar 22-24, 2017; Villach, Austria; MAR 22-24, 2017; Villach, AUSTRIA. [Oral Communication]

 

Koenig, W; Jaensch, A; Scharnagl, H; Mons, U; Breitling, LP; Brenner, H; Maerz, W; Rothenbacher, D Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study
EUR HEART J. 2016; 37: 404-404.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Poster]
Web of Science

 

Scharnagl, H; Kleber, ME; Grammer, TB; Stojakovic, T; Hoffmann, MM; Marz, W CV RISK FACTORS AND ATHEROSCLEROSIS II. APOLIPOPROTEIN CII AND CIII: PROGNOSTIC MARKERS OF CARDIOVASCULAR RISK?
ATHEROSCLEROSIS. 2016; 252: E217-E217.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Werner, C; Stojakovic, T; Marz, W; Laufs, U LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. ASSOCIATION OF THE POSTPRANDIAL CHYLOMICRON TRIGLYCERIDE/ APOB INDEX AND CARDIOVASCULAR EVENTS
ATHEROSCLEROSIS. 2016; 252: E99-E99.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. [Poster]
Web of Science FullText FullText_MUG

 

Schilcher, I; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S IMPACT OF ENDOTHELIAL LIPASE OVEREXPRESSION ON CHOLESTEROL EFFLUX CAPACITY OF SERUM, APOLIPOPROTEIN B-DEPLETED SERUM AND HDL
ATHEROSCLEROSIS. 2016; 252: E207-E207.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. [Poster]
Web of Science FullText FullText_MUG

 

Schilcher, I; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S Impact of endothelial lipase overexpression on cholesterol efflux capacity of serum, apolipoproteinB- depleted serum and HDL
European Atherosclerosis Society Congress; MAY 29 - June 1; Innsbruck, AUSTRIA. 2016. [Poster]

 

Schilcher, I; Kern, S; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S Impact of Endothelial Lipase overexpression on cholesterol efflux capacity of serum and apolipoprotein B-depleted serum as well as HDL
European Lipoprotein Club; SEPT 5-8, 2016; Tutzing, Germany. 2016. [Poster]

 

Voortman, MM; Bachmayer, D; Pekar, T; Seifert-Held, T; Archelos, J-J; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
Doctoral day Medical University of Graz; DEC 14, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Werner, C; Stojakovic, T; Maerz, W; Scharnagl, H; Laufs, U Association of the postprandial chylomicron triglyceride/apoB index and cardiovascular events
EUR HEART J. 2016; 37: 218-218.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Poster]
Web of Science

 

Woitas, R; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY
ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. [Poster]
Web of Science FullText FullText_MUG

 

Zewinger, S; Kleber, ME; Triem, S; Lehmann, M; Lepper, PM; Silbernagel, G; Scharnagl, H; Ritsch, A; Laufs, U; Fliser, D; Marz, W; Speer, T HIGH-DENSITY LIPOPROTEIN - SYMMETRIC DIMETHYLARGININE - A CKD-SPECIFIC ASSOCIATION PROMOTING PREMATURE CARDIOVASCULAR DISEASE
NEPHROL DIAL TRANSPL. 2016; 31: 181-181.-53rd ERA-EDTA Congress; MAY 21-24, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

Zöhrer, E; Malle, O; Scharnagl, H; Stojakovic, T; Fauler, G; Eber, E; Jahnel, J Serum bile acid levels in patients with cystic fibrosis.
-. 2016; -ESPGHAN Monothematic Conference on Cystic Fibrosis related Liver disease; JAN 28-29, 2016; Paris, France. [Oral Communication]

 

Dieplinger, H; Melmer, A; Kleber, M; Scharnagl, H; Marz, W AFAMIN - A NOVEL MARKER FOR THE PRESENCE AND INCIDENCE OF METABOLIC SYNDROME AND RELATED DISEASES
ATHEROSCLEROSIS. 83rd Congress of the European-Atherosclerosis-Society (EAS). 2015; 241(1):E174-E174.-83rd Congress of the European-Atherosclerosis-Society (EAS); MAR 22-25, 2015; Glasgow, SCOTLAND. [Poster]
Web of Science FullText FullText_MUG

 

Evelyn, Z; Heckmann, M; Frohlich-Reiterer, E; Jasser-Nitsche, H; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Bile acid metabolism is altered in adolescents with type 1 diabetes
HEPATOLOGY. . 2015; 62: 1050A-1050A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Jahnel, J; Zöhrer, E; Scharnagl, H; Erwa, W; Fauler, G; Stojakovic, T REFERENCE RANGES OF SERUM BILE ACIDS IN CHILDREN AND ADOLESCENTS.
Clin Chem Lab Med. 2015; 53(S1):S1184-S1184.-EuroMedLab, 21st IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine; JUN 21-25, 2015; Paris, FRANCE. [Poster]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F. Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
http://www.eaneurology.org/berlin2015/. 2015; -1st Congress of the European Academy of Neurology; June 20-23, 2015; Berlin, GERMANY. [Oral Communication]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F. Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation.
Neurologisch, Supplementum 2/2015. 2015; 2015(2):23-23.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. [Poster]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos-Garcia, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
EUR J NEUROL. 2015; 22: 87-87.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Koller, L; Kleber, ME; Brandenburg, VM; Goliasch, G; Scharnagl, H; Grammer, TB; Tomaschitz, A; Huelsmann, M; Maerz, W; Niessner, A Fibroblast growth factor 23 is an independent and specific predictor of mortality in patients with heart failure and reduced ejection fraction
EUR HEART J. 2015; 36: 1201-1201.-Congress of the European-Society-of-Cardiology (ESC); AUG 29-SEP 02, 2015; London, ENGLAND. [Keynote lecture]
Web of Science

 

Marsche, G; Schilcher, G; Scharnagl, H; Stojakovic, T; Rosenkranz, A; Holzer M Dialysis modalities, HDL metabolism and function
Symposium- Biomarker und Nierenerkrankungen ; JAN 16-17, 2015; Mannheim, GERMANY, 2014. 2015. [Poster]

 

Ritsch, A; Duerr, A; Kahler, P; Stojakovic, T; Silbernagel, G; Scharnagl, H; Kleber, ME; Marz, W HDL CHOLESTEROL EFFLUX CAPACITY AND CARDIOVASCULAR MORTALITY.
ATHEROSCLEROSIS. 2015; 241(1):E28-E28.-83rd Congress of the European-Atherosclerosis-Society (EAS); MAR 22-25, 2015; Glasgow, SCOTLAND. [Oral Communication]
Web of Science FullText FullText_MUG

 

Roob, JM; Faustmann, G; Kieslinger, P; Hafner-Giessauf, H; Walter, N; Grabher, J; Maimari, T; Sattler, MC; Meinitzer, A; Zelzer, S; Obermayer-Pietsch, B; Scharnagl, H; Erwa, W; Öttl, K; Tiran, B; Fauler, G; Winklhofer-Roob, BM Validation of new biomarkers in the BIOCLAIMS Integration study: Plasma acylcarnitines and amino acids, fatty acids, leptin/adiponectin, human mercaptalbumin and nuclear factor kB in study subjects with mildly impaired renal, vascular and metabolic health compared to “super-healthy” subjects.
In: J. Ribot, M.L.Bonet, N. Granados, P. Oliver, M. Palou, C. Pico, P.J. Pons, A. Palou (Hg.): Biomarkers and Health Claims on Food. . 2015; 94-94.-Biomarkers and Health Claims on Food; Feb 12-13, 2015; Palma de Mallorca, SPAIN. (ISBN: 978-84-606-5699-9 ) [Poster]

 

Scharnagl, H; Stojakovic, T; Dieplinger, B; Dieplinger, H; Kostner, G; März, W Quantitative Bestimmung von Lipoprotein(a): ein Vergleich kommerzieller Assays.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015. [Oral Communication]

 

Silbernagel G, Pagel P, Pfahlert V, Genser B, Scharnagl H, Kleber ME, Delgado G, Ritsch A, Grammer TB, Baumgartner I, Koenig W, März W High Density Lipoprotein Particles Predict All-cause and Cardiovascular Mortality
Circulation. 2015; (132): A1812--American Heart Association Scientific Sessions; Nov 7-11; Orlando, Florida, United States. [Poster]
FullText

 

Stojakovic, T; Voortman, MM; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Hematology Reports. 2015; 7(S1):67-67.-7th International Symposium on Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis; APR 16-17, 2015; Edinburgh, UNITED KINGDOM. [Poster]

 

Tripolt, N; Zedler, J; Scharnagl, H; Stojakovic, T; Sourij, H; Polyclonal serum free light chains levels are associated with carotid atherosclerosis in type 2 diabetes mellitus.
WIEN KLIN WOCHENSCHR. Wiener Kliinische Wochenschrift, Supplement 3/15. 2015; 127(127):S143-S143.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Voortman, M M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M. Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. 2015. [Poster]

 

Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Voortman, M.M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J.J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Eur J Neurol. 2015; 22(S1):398-398.-1st Congress of the European Academy of Neurology (EAN); JUN 20-23, 2015; Berlin, GERMANY. [Poster]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid immunoglobulin free light chains as diagnostic and prognostic tool in clinically isolated syndrome and multiple sclerosis.
Inflame Symposium on Inflammation & Immunology; SEP 14-15, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Neurologisch, Supplementum 2/2015. 2015; 2: 25-25.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27, 2015; Graz, AUSTRIA. [Poster]

 

Voortman, MM; Stojakovic, T;Jehna, M;Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients.
Multiple Sclerosis Journal. 2015; 21(S11):630-630.-31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 7-10, 2015; Barcelona, SPAIN. [Poster]
FullText

 

Wakula, P; Neumann, B; Kienemund, J; Thon-Gutschi, E; Stojakovic, T; Scharnagl, H; Pieske, B; Kapl, M; Heinzel, FR Comparison of emerging blood biomarkers, NTproBNP and the CHA2DS2-VASc score in the prediction of paroxysmal atrial fibrillation in patients with continuous rhythm monitoring.
EUR HEART J. 2015; 36: 913-913.-Congress of the European-Society-of-Cardiology (ESC); AUG 29 - SEP 02, 2015; London, UNITED KINGDOM. [Poster]
Web of Science

 

Werner, C; Stojakovic, T; März, W; Scharnagl, H; Laufs, U Das postprandiale Chylomikronen-Triglyzerid/ApoB-Verhältnis ist ein potentieller Prädiktor für kardiovaskuläre Ereignisse in Statin-behandelten Patienten mit stabiler koronarer Herzkrankheit.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015. [Oral Communication]

 

Woitas, R; Scharnagl, H; Kleber, ME; Grammer, TB; Pichler, M; März, W; Stojakovic, T Impact of neutrophil gelatinase-associated lipocalin and neutrophil counts in the Ludwigshafen Risk and Cardiovascular Health Study.
45. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2015; Maikammer, GERMANY. 2015. [Oral Communication]

 

Zewinger, S; Speer, T; Drechsler, C; Kleber, ME; Dressel, A; Riffel, J; Lehmann, M; Kopecky, C; Saemann, MD; Lepper, PM; Silbernagel, G; Scharnagl, H; Ritsch, A; Laufs, U; Wanner, C; Fliser, D; Marz, W SERUM AMYLOID A (SAA) AND HIGH DENSITY LIPOPROTEINS (HDL) INTERACTION AND CARDIOVASCULAR RISK IN RENAL PATIENTS
NEPHROL DIAL TRANSPL. 2015; 30: -52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation; MAY 28-31, 2015; London, ENGLAND. [Poster]
Web of Science FullText FullText_MUG

 

Zöhrer, E; Heckmann, M; Fröhlich-Reiterer, E; Jasser-Nietsche, H; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?
Z Gastroenterol. 2015; 53(5):499-499.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]

 

Zöhrer, E; Heckmann, M; Fröhlich-Reiterer, E; Jasser-Nitsche, H; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Serum Gallensäuren bei Jugendlichen mit Typ 1 Diabetes
-. 2015; -30.Jahrestagung der GPGE ; APR 23-25, 2015; Berlin, Austria. [Poster]

 

Zöhrer, E; Heckmann, M; Fröhlich-Reiterer, E; Jasser-Nitsche, H; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Bile acid metabolism is altered in adolescents with type 1 diabetes
-. 2015; -AASLD (American Association for the Study of Liver Diseases) 2015; NOV 13-17, 2015; San Francisco, CA, USA. [Poster]

 

Zöhrer, E; Heckmann, M; Fröhlich-Reiterer, E; Jasser-Nitsche, H; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Serum Bile Acids in Children and Adolescents with Type 1 Diabetes
-. 2015; -48th Annual Meeting of ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition); MAY 6-9, 2015; Amsterdam, NETHERLANDS. [Oral Communication]

 

Zöhrer, E; Jahnel, J; Fauler, G; Scharnagl, H; Stojakovic, T; Trauner, M; Nobili, V NONALCOHOLIC FATTY LIVER DISEASE: SERUM BILE ACID LEVELS IN CHILDREN AND ADOLESCENTS AS MARKER FOR PROGRESSION?
J HEPATOL. 2015; 62(S2):S717-S717.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. [Poster]
Web of Science

 

Zöhrer, E; Jahnel, J; Fauler, G; Scharnagl, H; Stojakovic, T; Trauner, M; Nobili, V Serum bile acid levels in children and adolescents with nonalcoholic fatty liver disease: a marker for progression
-. 2015; -EASL (European Association for the Study of the Liver) Monothematic Conference: Microbiota, Metabolism and NAFLD; FEB 26-28, 2015; Innsbruck, Austria. [Poster]

 

Zöhrer, E; Resch, B; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Normal Values of Serum Bile Acids in Neonates
Proceedings of the 48th Annual Meeting of ESPGHAN . 2015; -48th Annual Meeting of ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition); MAY 6-9, 2015; Amsterdam, NETHERLANDS. [Poster]

 

Zöhrer, E; Resch, B; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J SERUM BILE ACIDS IN NEONATES: DETERMINATION OF NORMAL VALUES IN FED AND FASTENED CONDITION.
J HEPATOL. 2015; 62(S2):S816-S816.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. [Poster]
Web of Science

 

Delgado, G; Kleber, ME; Grammer, TB; Kraemer, BK; Maerz, W; Scharnagl, H ALTERATIONS OF LIPOPROTEIN CONSTITUTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE SHOWED NO EVIDENCE FOR AN INCREASE OF SMALL DENSE LDL - RESULTS FROM THE LURIC STUDY
NEPHROL DIAL TRANSPL. 2014; 29: 156-156.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Fauler, G; Silbernagel, G; Genser, B; Krane, V; Drechsler, C; Scharnagl, H; Ritz, E; Wanner, C; Marz, W CHOLESTEROL ABSORPTION PREDICTS THE EFFECTIVENESS OF ATORVASTATIN FOR PREVENTING CARDIOVASCULAR END POINTS IN DIABETIC HEMODIALYSIS PATIENTS
ATHEROSCLEROSIS. 2014; 235(2):E74-E74.-82nd Congress of the European-Atherosclerosis-Society (EAS); MAY 31-JUN 03, 2014; Madrid, SPAIN. [Poster]
Web of Science FullText FullText_MUG

 

Frank, S; Opresnik, S; Rao, SP; Hrzenjak, A; Hallstrom, S; Kozina, A; Sreckovic, I; Wadsack, CH; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H ENDOTHELIAL LIPASE ATTENUATES VASORELAXING CAPACITY OF HDL
ATHEROSCLEROSIS. 2014; 235(2): E45-E45. [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Scharnagl, H; Österreicher, C; Hoesel, B; Paumgartner, G; Marschall, HU; Trauner, M ABCB11 (BSEP) knockout mice are proteced from methionine choline deficient diet induced steatohepatitis.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Grammer, TB; Kleber, M; Maerz, W; Silbernagel, G; Siekmeier, R; Pilz, S; Tomaschitz, A; Konig, W; Scharnagl, H Particle Diameter in the Low Density Lipoprotein as Mortality Factor- Results from Ludwigshafen Risk and Cardiovascular Health Study(LURIC)
WIEN KLIN WOCHENSCHR. 2014; 126: S133-S134.
Web of Science

 

Hörl, G; Froehlich, H; Ferstl, U; Ledinski, G; Binder, J; Cvirn, G; Stojakovic, T; Trauner, M; Koidl, C; Tafeit, E; Hallström, S; Amrein, K; Scharnagl, H; Jürgens, G Simvastatin lowers polyethylene glycol-non -precitable LDL-single-IgG-immune complexes.
21. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 9-10, 2014; St. Gilgen, AUSTRIA. 2014. [Oral Communication]

 

J. Jahnel, M. Koren, T. Stojakovic, H. Scharnagl, W. Erwa, K.-M. Hoffmann, A. Deutschmann, G. Grangl, A. C. Hauer Formation of Antibodies against Infliximab in Paediatric Crohn’s Disease
JPGN (online Publikationen), IF: 2.873. 2014; -47th Annual Meeting ESPGHAN; June 9-12, 2014; Jerusalem. [Oral Communication]

 

Jahnel, J; Pircher, K; Fauler, G; Stojakovic, T; Scharnagl, H; Erwa,W; Hoffmann, KM; Deutschmann, A; Grangl, G; Koestenberger, M; Hauer, AC Bile acids in congenital heart disease
47th Annual Meeting of the Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); JUN, 2014; Jerusalem, ISRAEL. 2014. [Oral Communication]

 

Jahnel, J; Zoehrer, E; Fauler, G; Scharnagl, H; Stojakovic, T; Nobili, V Bile acid serum levels in adolescents with NAFLD: a biomarker for progression?
HEPATOLOGY. 2014; 60: 615A-615A.-65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 07-11, 2014; Boston, USA. [Poster]
Web of Science

 

Jahnel, J; Zöhrer, E; Fauler, G; Scharnagl, H; Stojakovic, T; Nobili, V Serum bile acid levels in adolescents with nonalcoholic fatty liver disease (NAFLD): A non-invasive marker for progression?
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
NCA NUBIN 2014 Symposium - The 5th biannual symposium on body fluid biomarkers for inflammation and neurodegeneration.; October 29-30, 2014; Amsterdam, THE NETHERLANDS. 2014. [Oral Communication]

 

Koller, L; Kleber, ME; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, T; Pilz, S; Maerz, W; Niessner, A C-reactive protein and NT-proBNP for predicting mortality in patients with heart failure with preserved ejection fraction
EUR HEART J. 2014; 35: 871-871.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN. [Poster]
Web of Science

 

Kozina, A; Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S Endothelial lipase attenuates vasorelaxing capacity of HDL
Book of Abstracts. 2014; -21st Annual Meeting of the Austrian Atherosclerosis Society; May 9-10, 2014; St. Gilgen/ Wolfgangsee. [Oral Communication]

 

Locatelli, F; Choukroun, G; Fliser, D; Moecks, J; Wiggenhauser, A; Gupta, A; Swinkels, DW; Lin, V; Guss, C; Pratt, R; Carrilho, P; Martins, AR; Alves, M; Mateus, A; Gusmao, L; Parreira, L; Assuncao, J; Rodrigues, I; Stamopoulos, D; Mpakirtzi, N; Afentakis, N; Grapsa, E; Zitt, E; Sturm, G; Kronenberg, F; Neyer, U; Knoll, F; Lhotta, K; Weiss, G; Robinson, BM; Larkina, M; Bieber, B; Kleophas, W; Li, Y; Locatelli, F; McCullough, K; Nolen, JG; Port, FK; Pisoni, RL; Kalicki, RM; Uehlinger, DE; Ogawa, C; Kanda, F; Tomosugi, N; Maeda, T; Kuji, T; Fujikawa, T; Shino, M; Shibata, K; Kaneda, T; Nishihara, M; Satta, H; Kawata, S; Koguchi, N; Tamura, K; Hirawa, N; Toya, Y; Umemura, S; Chanliau, J; Martin, H; Stamatelou, K; Gonzalez-Tabares, L; Manamley, N; Farouk, M; Addison, J; Donck, J; Schneider, A; Gutjahr-Lengsfeld, L; Ritz, E; Scharnagl, H; Gelbrich, G; Pilz, S; Macdougall, IC; Wanner, C; Drechsler, C; Kuntsevich, V; Charen, E; Kobena, D; Sheth, N; Siktel, H; Levin, NW; Winchester, JF; Kotanko, P; Kaysen, G; Kuragano, T; Kida, A; Yahiro, M; Nanami, M; Nagasawa, Y; Hasuike, Y; Nakanishi, T; Stamopoulos, D; Mpakirtzi, N; Dimitratou, V; Griveas, I; Lianos, E; Grapsa, E; Sasaki, Y; Yamazaki, S; Fujita, K; Kurasawa, M; Yorozu, K; Shimonaka, Y; Suzuki, N; Yamamoto, M; Zwiech, R; Szczepańska, J; Bruzda-Zwiech, A; Rao, A; Gilg, J; Caskey, F; Kirkpantur, A; Balci, MM; Turkvatan, A; Afsar, B; Alkis, M; Mandiroglu, F; Kim, YO; Yoon, SA; Kim, YS; Choi, SJ; Min, JW; Cheong, MA; Hasuike, Y; Kida, A; Oue, M; Yamamoto, K; Kimura, T; Fukao, W; Yahiro, M; Kaibe, S; Nanami, M; Nakanishi, T; Djuric, PS; Ikonomovski, J; Tosic, J; Jankovic, A; Majster, Z; Stankovic Popovic, V; Dimkovic, N; Aicardi Spalloni, V; Del Vecchio, L; Longhi, S; Violo, L; La Milia, V; Pontoriero, G; Locatelli, F; Shino, M; Kuji, T; Fujikawa, T; Toya, Y; Umemura, S; Macdougall, I; Rumjon, A; Mangahis, E; Goldstein, L; Ryzlewicz, T; Becker, F; Kilgallon, W; Fukasawa, M; Otake, Y; Yamagishi, T; Kamiyama, M; Kobayashi, H; Takeda, M; Toida, T; Sato, Y; Fujimoto, S Dialysis anaemia.
Nephrol Dial Transplant. 2014; 29 Suppl 3: iii491-iii500-iii491-iii500. [Poster]
PubMed FullText FullText_MUG

 

Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S Endothelial Lipase Attenuates Vasorelaxing Capacity of HDL.
keine. 2014; -7th IAS Workshop on HDL; März 24-26, 2014; Rom, Italien. [Poster]

 

Rinde, H; Genser, B; Sonntag, D; Kleber, ME; Stojakovic, T; Scharnagl, H; Maerz, W COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF RISK STRATIFICATION OF PATIENTS WITH MODERATE RISK OF CARDIOVASCULAR EVENTS USING LP-PLA2 TESTING
VALUE HEALTH. 2014; 17(7): A481-A481.
Web of Science FullText FullText_MUG

 

Scharnagl, H; Grammer, TB; Kleber, ME; Stojakovic, T; März, W LDL triglycerides, but not LDL cholesterol predict mortality in the LURIC study.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Scharnagl, H; Hoffmann, MM; Kleber, ME; Grammer, TB; Stojakovic, T; März, W Apolipoprotein CII und CIII: prognostische Marker für das kardiovaskuläre Risiko?
44. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 27-29, 2014; Maikammer, GERMANY. 2014. [Oral Communication]

 

Scharnagl, H; Kleber, ME; Stojakovic, T; Grammer, TB; März, W; Brandenburg, VM Fibroblast growth factor 23 (FGF-23) and mortality (The Ludwigshafen Risk and Cardiovascular Health Study).
21. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 9-10, 2014; St. Gilgen, AUSTRIA. 2014. [Oral Communication]

 

Scharnagl, H; Stojakovic, T; Kleber, ME; Grammer, TB; März, W Low density lipoprotein triglycerides and mortality: The Ludwigshafen Risk and Cardiovascular Health Study.
The 2nd World Congress of Clinical Lipidology; DEC 5-7, 2014; Vienna, AUSTRIA. 2014. [Oral Communication]

 

Scharnagl, H; Weihrauch, G; Grammer, TB; Kleber, ME; Stojakovic, T; März, W Interleukin-6 out-performs CRP as a predictor of long-term mortality in the LURIC study.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Schneider, A; Gutjahr-Lengsfeld, L; Ritz, E; Scharnagl, H; Gelbrich, G; Pilz, S; Macdougall, IC; Wanner, C; Drechsler, C LONGITUDINAL ASSESSMENTS OF ESA RESPONSIVENESS AND THE ASSOCIATION WITH SPECIFIC CLINICAL OUTCOMES IN DIALYSIS PATIENTS
NEPHROL DIAL TRANSPL. 2014; 29: 494-494.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Stojakovic, T; Ebner, N; Scharnagl, H; Földes, G; Döhner, W; Anker, SD; von Haehling, S. Lipoproteins in heart failure patients with and without lipid-lowering drugs – a pilot study.
The 2nd World Congress of Clinical Lipidology; DEC 5-7, 2014; Vienna, AUSTRIA. 2014. [Poster]

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Ischemia Modified Albumin (IMA): diagnostic potential value beyond cardiac troponins.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Stojakovic, T; Zöhrer, E; Stering, B; Fauler, G; Scharnagl, H; Hauer, AC; Jahnel, J Serum bile acid levels in children and adolescents.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Woitas, R; Scharnagl, H; Kleber, ME; Grammer, TB; Meinitzer, A; Silbernagel, G; Pilz, S; Tomaschitz, A; März, W, Stojakovic, T NGAL and mortality in the LURIC study.
Symposium Biomarker und Nierenerkrankungen, 15 Jahre 4D-Studie; JAN 17-18, 2014; Würzburg, GERMANY. 2014. [Poster]

 

Wultsch, A; Kaufmann, U; Stojakovic, T; Scharnagl, H; Stangl, H; Strobl, W Effect of cross gender hormone therapy on serum cholesterol acceptor capacity in transsexuals.
21. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 9-10, 2014; St. Gilgen, AUSTRIA. 2014. [Oral Communication]

 

Zewinger, S; Speer, T; Kleber, ME; Scharnagl, H; Woitas, R; Pfahler, K; Seiler, S; Heine, GH; Lepper, PM; Marz, W; Silbernagel, G; Fliser, D HDL CHOLESTEROL IS NOT VASOPROTECTIVE IN PATIENTS WITH IMPAIRED RENAL FUNCTION
NEPHROL DIAL TRANSPL. 2014; 29: 133-133.-51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA); MAY 31-JUN 03, 2014; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Zöhrer, E; Grangl, G; Jud, A; Pircher, K; Fauler, G; Scharnagl, H; Stojakovic, T; Köstenberger, M; Jahnel, J Serum bile acid levels in tetralogy of Fallot: a non-invasive marker for heart insufficiency
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Zöhrer, E; Jahnel, J; Fauler, G; Scharnagl, H; Stojakovic, T; Paumgartner, G; Nobili, V. Nonalcoholic fattly liver disease and bile acids in adolescents
-. 2014; -4th European Lipidomic Meeting; SEPT 22 - 24, 2014; Graz, AUSTRIA. [Poster]

 

Zöhrer, E; Stering, B;Hauer, AC; Fauler, G; Scharnagl, H; Stojakovic, T; Jahnel, J Gallensäuren im Serum bei Kindern und Jugendlichen: Festlegung von altersabhängigen Referenzbereichen.
-. 2014; -52. Jahrestagung der ÖGKJ; SEPT 17-19, 2014; Wien . [Oral Communication]

 

Zuser, G; Fett, S; Lackner, G; Luttenberger, B; Schafranek, S; Schweighofer, B; Waitzl, B; Scharnagl, H; Koidl, C Comparison of two ELISA-HCV-antibody tests with different antigen components used in basic diagnostics.
34. Jahrestagung der Österreichischen Gesellschaft f. Hygiene, Mikrobiologie und Präventivmedizin; JUN 2-5, 2014; Bad Ischl, Austria. 2014. [Poster]

 

Delgado, G; Kleber, M; Siekmeier, R; Marz, W; Scharnagl, H; Enrichment of triglyceride-rich Particles with no Evidence of small dense LDL (sdLDL) in LURIC Patients with impaired Renal Function.
WIEN KLIN WOCHENSCHR. . 2013; 125(17-18):569-570. [Poster]
Web of Science

 

Delgado, G; Siekmeier, R; Grammer, T; Scharnagl, H; Marz, W; Highly sensitive CRP (hsCRP) and Myeloperoxidase (MPO) in Smokers and Non-smokers in the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):567-568. [Poster]
Web of Science

 

Dieplinger, B; Egger, M; Haltmayer, M; Kleber, ME; Scharnagl, H; Silbernagel, G; Grammer, TB; Maerz, W; Mueller, T; Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease.
EUR HEART J. 2013; 34: 504-504.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Doyon, A; Scharnagl, H; Kracht, D; Zeller, R; Anarat, A; Mir, S; Sander, A; Melk, A; Querfeld, U; Schaefer, F; Prediction of Chronic Kidney Disease (CKD) Progression in Children by Urinary Neutrophil-Associated Lipocalin (NGAL).
PEDIAT NEPHROL. 2013; 28(8):1359-1360. [Poster]
Web of Science

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, A; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurological Sciences. 2013; -XXI World Congress od Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545. [Poster]
Web of Science

 

Khalil, M; Riedlbauer, B;Langkammer, C;Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, J.J; Fuchs, S; Fazekas, F Cerebrospinal fluid (CSF) transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurology. 2013; 260, Supplement 1: 39-40.-Twenty-Third Meeting of the European Neurologic Society; JUN 8-11, 2013; Barcelona, SPAIN. [Oral Communication]

 

Opresnik, S; Rao, SP; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Grünberger, R; Stojakovic, T; Scharnagl, H; Frank, S Endothelial lipase attenuates vasorelaxing capacity of HDL
43. Jahrestagung des Arbeitskreises ''Klinischer Lipidstoffwechsel'' Maikammer 2013; NOV 28-30, 2013; Maikammer, Deutschland. 2013. [Oral Communication]

 

Pekar, T; Stojakovic, T; Haas, J; Simmet, NE; Scharnagl, H; Gattringer, T; Fazekas, F; Storch, MK; Seifert-Held, T Plasma neutrophil gelatinase-associated lipocalin and functional outcome in ischemic stroke
J Neurol Sci. 2013; 333 Suppl 1: e171-e171.-XXI World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Scharnagl, H; Grammer, TB; Kleber ME; Stojakovic, T; Kassner, U; Steinhagen-Thiessen, E; März, W Prevalence and characteristics of autosomal dominant hypercholesterolemia in persons scheduled for angiography.
Symposium Biomarker und Gefäßerkrankungen, 15 Jahre LURIC-Studie; JAN 18-19, 2013; Mannheim, GERMANY. 2013. [Poster]

 

Schilcher, G; Schneditz, D; Schlagenauf, A; Scharnagl, H; Ribitsch, W; Krause, R; Rosenkranz, AR; Stojakovic, T; Horina, JH Ethanol lock technique causes protein precipitation and occlusion of vascular access devices
The Journal of Vascular Access. 2013; 14(1):62-62.-International Congress on Vascular Access; 25-27 April, 2013; Prague, Czech Republik. [Poster]

 

Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Bocksrucker, C; Lampl, C; Storch, MK; Stojakovic, T; Fazekas, F Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke
J Neurol Sci. 2013; 333 Suppl 1: e171-e172.-XXI World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; Maerz, W Ischemia modified albumin: diagnostic potential value beyond cardiac troponins.
EUR HEART J. 2013; 34: 1020-1020.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Ischemia Modified Albumin (IMA): diagnostic potential value beyond cardiac troponins.
Symposium Biomarker und Gefäßerkrankungen, 15 Jahre LURIC-Studie; JAN 18-19, 2013; Mannheim, GERMANY. 2013. [Poster]

 

Ebner, N; Stojakovic, T; Scharnagl, H; Földes, G; Döhner, W; Anker, SD; von Haehling, S Comparison of lipoprotein measurement in heart failure patients with and without lipid lowering drugs.
42. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29-DEC 1, 2012; Maikammer, GERMANY. 2012. [Oral Communication]

 

Maerz, W; Genser, B; Benz, J; Drechlser, C; Krane, V; Grammer, TB; Ritz, E; Scharnagl, H; Wanner, C Lipoprotein-associated phospholipase A2 (LpPLA2), cardiovascular events and mortality in patients with type 2 diabetes mellitus on hemodialysis.
EUR HEART J. 2012; 33: 1077-1077.-Congress of the European-Society-of-Cardiology (ESC); AUG 25-29, 2012; Munchen, GERMANY. [Poster]
Web of Science

 

Pätzold, S; Scharnagl, H; Colantonio, C; Pieske, B; Stojakovic, T Evaluation of copeptin in early diagnosis of patients with acute coronary syndrome.
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):576-576.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 20-22, 2012; Graz, AUSTRIA. [Poster]
Web of Science

 

Pekar, T; Stojakovic, T; Haas, J; Simmet, N; Scharnagl, H; Gattringer, T; Fazekas, F; Storch, M; Seifert-Held, T Neutrophil gelatinase-associated lipocalin after acute ischemic stroke: relation to post-stroke infections and long-term outcome
neurologisch; Supplementum 1/2012. 2012; 91--10. Jahrestagung der österreichischen Gesellschaft für Neurologie; MAR 14 - 17, 2012; Graz, AUSTRIA. [Poster]

 

Schilcher, G; Scharnagl, H; Stojakovic, T; Ribitsch, W; Schneditz, D; Krause, R; Rosenkranz, AR; Horina, JH Ethanol lock technique causes protein precipitation in vascular access devices – an explanatory model for catheter occlusion
Abstracts ASN 2012. 2012; -American Society of Nephrology Kidney Week (ASN); Oct30-Nov4, 2012; San Diego, CA, USA. [Poster]

 

Schilcher, G; Scharnagl, H; Stojakovic, T; Ribitsch, W; Schneditz, D; Krause, R; Rosenkranz, AR; Horina, JH Ethanol lock technique causes protein precipitation in vascular access devices - an explanatory model for observed catheter occlusion.
Nephro Script. Abstracts 2012 zur Jahrestagung der Österreichischen Gesellschaft für Nephrologie und der Österreichischen Gesellschaft für Hypertensiologie Graz, 7.-8. September. 2012; 20-20.-Jahrestagung der Österreichischen Gesellschaft für Nephrologie (OEGN); Sept 7-8, 2012; Graz, Austria. [Poster]

 

Schilcher, G; Scharnagl, H; Stojakovic, T; Ribitsch, W; Schneditz, D; Krause, R; Rosenkranz, AR; Horina, JH Ethanol lock induced intraluminal plasma protein precipitation might cause occlusion of hemodialysis access devices
Wiener Klinische Wochenschrift. 2012; 124(15-16):582-583.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Sept 20-22, 2012; Graz. [Poster]
Web of Science

 

Schilcher, G; Schneditz, D; Scharnagl, H; Ribitsch, W; Krause, R; Rosenkranz, AR; Stojakovic, T; Horina JH Ethanol lock technique causes protein precipitation in vascular access devices – an explanatory model for observed catheter occlusion
Abstract-Band der Jahrestagung der Deutschen Gesellschaft für Nephrologie. 2012; -Kongress für Nephrologie Jahrestagung der Deutschen Gesellschaft für Nephrologie; Oct 6-9, 2012; Hamburg. [Poster]

 

Schreier, SM; Hollaus, M; Ammann, M; Pemberger, E; Liebscher, F; Fruhwürth, S; Stojakovic, T; Scharnagl, H; Schmidt, A; Becker, J; Handisurya, A; Springer, A; Saemann, M; Aufricht, C; Stangl, H; Strobl, W Reduced serum cholesterol acceptor capacity and increased macrophage cholesterol export capacity in patients with chronic renal failure on hemodialysis.
19. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 11-12, 2012; St. Gilgen, AUSTRIA. 2012. [Oral Communication]

 

Froehlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T Simvastatin improves endothelial function in patients with cardiovascular disease but not in patients with peripheral artery disease.
18. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 6-7, 2011; St. Gilgen, AUSTRIA. 2011. [Oral Communication]

 

Froehlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T Simvastatin improves endothelial function in patients with cardiovascular disease but not in patients with peripheral artery disease.
41. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 24-26, 2011; Maikammer, GERMANY. 2011. [Oral Communication]

 

Froehlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T SIMVASTATIN IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH CARDIOVASCULAR DISEASE BUT NOT IN PATIENTS WITH PERIPHERAL ARTERY DISEASE.
ATHEROSCLER SUPPL. 2011; 12(1):173-174.-79th Congress of the European Atherosclerosis Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN. [Poster]
Web of Science FullText FullText_MUG

 

Frohlich, H; Hafner, F; Binder, J; Amrein, K; Scharnagl, H; Brodmann, M; Stojakovic, T Simvastatin improves endothelial function in patients with cardiovascular disease but not in patients with peripheral artery disease.
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A54-A54.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

Fröhlich, H; Hafner, F; Binder,J; Amrein,K; Scharnagl, H; Brodmann,M; Stojakovic,T Simvastatin imporves endothelial function in patients with cardiovascular disease but not in patinets with peripheral arterial disease
Zeitschrift für Gefäßmedizin 2011. 2011; 8(4):16-16.-Jahrestagung der ÖGIA und 6.Sailersymposium; NOV 25-26, 2011; Graz. [Poster]

 

Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Stojakovic, T; Fazekas, F; Storch, MK; Seifert-Held, T Elevated plasma levels of Dickkopf-1 in acute ischemic stroke
Jatros Neurologie & Psychiatrie; Abstractband. 2011; 19(2):12--11. Neuroscience Wintermeeting; MAR 31 - APR 2; Kitzbühel, AUSTRIA. [Poster]

 

Schilcher, G; Scharnagl, H; Horina, JH; Ribitsch, W; Rosenkranz, AR; Stojakovic, T; Polaschegg HD Trisodium citrate induced protein precipitation in hemodialysis catheters might cause pulmonary embolism
Abstracts, Jahrestagung ÖGN. 2011; -Jahrestagung der Österreichischen Gesellschaft für Nephrologie (ÖGN); Nov, 4-5, 2011; Gmunden, Austria. [Oral Communication]

 

Schilcher, G; Scharnagl, H; Ribitsch, W; Horina, JH; Rosenkranz, AR; Stojakovic, T; Polaschegg, HD Hypertonic citrate catheter lock causes protein precipitation
http://www.asn-online.org/education_and_meetings/kidneyweek/archives/KW11Abstracts.pdf. 2011; -American Society of Nephrology (ASN), 2011 Annual Meeting; Nov 10-13, 2011; Philadelphia, USA. [Poster]

 

Schilcher, G; Scharnagl, H; Ribitsch, W; Horina, JH; Rosenkranz, AR; Stojakovic, T; Polaschegg, HD Hypertonic citrate catheter lock causes protein precipitation
Abstracts from the XXXVIII Congress of the European Society for Artificial Organs (ESAO 2011) and IV Biennial Congress of the International Federation on Artificial Organs (IFAO 2011); Artificial Organs, Volume 35, Issue 9, pages A49–A141, September 2011. 2011; -XXXVIII Congress of the European Society for Artificial Organs (ESAO 2011); Oct 9-12, 2011; Porto, Portugal. [Poster]

 

Schreier, S; Hollaus, M; Pemberger, E; Fruhwurth, S; Rohrl, C; Liebscher, F; Englinger, B; Becker, J; Schmidt, A; Scharnagl, H; Aufricht, C; Stangl, H; Strobl, W EFFECT OF CHRONIC RENAL FAILURE ON SERUM AND HDL CHOLESTEROL EFFLUX CAPACITY AND MACROPHAGE ABCA1/ABCG1 EXPRESSION
ATHEROSCLEROSIS SUPP. 2011; 12(1): 45-46.
Web of Science FullText FullText_MUG

 

Schreier, SM; Ammann, M; Pemberger, E; Fruhwürth, S; Röhrl, C; Becker, J; Schmidt, A; Scharnagl, H; Stojakovic, T; Aufricht, C; Stangl, H; Strobl, W In vitro carbamylation but not chronic renal failure reduces the cholesterol efflux capacity of HDL
18. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 6-7, 2011; St. Gilgen, AUSTRIA. 2011. [Oral Communication]

 

Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, N; Scharnagl, H; Stojakovic, T; Fazekas, F; Storch, MK Elevated plasma levels of Dickkopf-1 in acute ischemic stroke
neurologisch2011; Supplementum 1/2011: 73-73.-9. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, AUSTRIA. [Poster]

 

Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Stojakovic, T; Fazekas, F; Storch, MK Elevated plasma levels of Dickkopf-1 in acute ischaemic stroke.
J NEUROL. 2011; 258: 176-176.-21st Meeting of the European Neurological Society (ENS); MAY 28-31, 2011; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE Alpha-fetoprotein and des-gamma-carboxy prothrombin as serum markers for hepatocellular carcinoma.
Clin Chem Lab Med 2011; 49: S275-S275.-IFCC WorldLab and EuroMedLab; MAY 15-19, 2011; Berlin, GERMANY. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE EVALUATION OF FOUR DIFFERENT TUMOR MARKERS FOR HEPATOCELLULAR CARCINOMA
J HEPATOL. 2011; 54: S401-S401. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE Evaluation of specific tumor markers for hepatocellular carcinoma.
Clin Chem Lab Med. 2011; 49(10):A25-A26.-Annual Assembly of the Swiss Society of Clinical Chemistry & Tri-National Congress of Laboratory Medicine; NOV 2-4, 2011; Zurich, SWITZERLAND. [Poster]

 

Augsten, M;Scharnagl, H;Gülly,C;Ebner,B;Chemelli,A;Glatter,O;Hackl,H;Lang,U;Desoye,G;Wadsack,Chr; HDL:A novel fetal signal regulationg placental functions.
WS09/10, S.19, P012010; -Abstract:3rd DocDay NAWI Graz Doctoral School of Molecular Biosciences and Biotechnology; Februar 2010; Graz. [Keynote lecture]

 

Dobnig, H; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W INFLUENCE OF 25-HYDROXYVITAMIN D STATUS ON SERUM PARATHYROID HORMONE LEVELS VARIES WITH KDOQI CLASSIFICATION OF RENAL FUNCTION AND IS INDEPENDENT OF 1,25 DIHYDROXYVITAMIN D CONCENTRATIONS
OSTEOPOROSIS INT. 2010; 21: 11-11. -IOF World Congress on Osteoporosis 10Th European Congress on Clinical an Economic Aspects of Osteoporosis and Osteoarthritis ; 5-8 May ; Florence, Italy. [Oral Communication]
Web of Science FullText

 

Eller, P; Ritsch, A; Scharnagl, H; Tancevski, I; Duwensee, K; Demetz, E; Sandhofer, A; Boehm, B; Winkelmann, B; Patsch, J; Marz, W CHOLESTERYL ESTER TRANSFER PROTEIN AND MORTALITY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
ATHEROSCLER SUPPL. 2010; 11(2):P259--78th Congress of the European Atherosclerosis Society; JUNE 20-23, 2010; Hamburg, GERMANY. [Poster]
Web of Science FullText FullText_MUG

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Lipoproteins and the development of re-obstruction after stent implantation in the superficial femoral artery in patients with peripheral artery disease.
17. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 7-8, 2010; St. Gilgen, AUSTRIA. 2010. [Oral Communication]

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Lipoproteins and the development of re-obstruction after stentimplantation in the superficial femoral artery in patients with peripheral artery disease
Wiener Klinische Wochenschrift 20102010; 122: A5-A5.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEPT 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M PARAMETERS OF THE LIPID PROFILE AND ASSOCIATION WITH THE DEVELOPMENT OF RE-OBSTRUCTION AFTER STENT IMPLANTATION IN THE SFA IN PAD-PATIENTS
ATHEROSCLER SUPPL. 2010; 11(2):P292--78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY. [Poster]
Web of Science FullText FullText_MUG

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Lipoproteins and the development of re-obstruction after stentimplantation in the superficial femoral artery in patients with peripheral artery disease
Vasa2010; Suppl. 79: 57-57.-15. Dreiländertagung der Schweizerischen, Deutschen und Österreichischen Gesellschaft für Angiologie; SEP 12-15, 2010; Basel, Schweiz. [Oral Communication]

 

Gary, T; Rief, P; Stojakovic, T; Froehlich, H; Scharnagl, H;Hafner, F; Pilger, E; Brodmann, M Parameters of the lipid profile and their association with the development of re-obstruction after stentimplantation in the superficial femoral artery in patients with peripheral arterial disease
Hämostasiologie Jänner 20102010; 30: 118--1.Joint Meeting GTH&NVTH: 54. Jahrestagung der GTH& Symposium van de Nederlandse Vereniging voor Trombose en Hemostase; Feb 24-27, 2010; Nuernberg, Deutschland. [Poster]

 

Grammer, TB; März, W; Genser, B; Drechsler, C; Krane, V; Ritz, E; Stojakovic, T; Scharnagl, H; Holme, I; Holdaas, H; Wanner, C Herz und Niere: Wirkung von Atorvastatin bei Patienten mit dialysepflichtiger Niereninsuffizienz und hohem LDL-Cholesterin.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Putz-Bankuti, C; Stojakovic, T; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, R Reduction of serum leptin levels during antiviral treatment with peginterferon and ribavirin in patients with chronic hepatitis C
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A10.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Scharnagl, H; Stojakovic, T; Weihrauch, G; Winkelmann, BR; Boehm, BO; Maerz, W INTERLEUKIN-6 IS STRONGER ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY THAN C-REACTIVE PROTEIN, SERUM AMYLOID A AND FIBRINOGEN (THE LURIC STUDY)
ATHEROSCLER SUPPL. 2010; 11(2):P124--78th Congress of the European Atherosclerosis Society; JUNE 20-23, 2010; Hamburg, GERMANY. [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Weihrauch, G; Dobnig, H; Stojakovic, T; Meinitzer, A; Winkelmann, BR; Boehm, BO; März, W The association of cystatin C, serum creatinine and creatinine clearance with cardiovascular mortality in the LURIC study.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Schreier, SM; Liebscher, F; Englinger, B; Stambera, B; Schmidt, A; Mühl, A; Scharnagl, H; Stangl, H; Strobl, WM Effect of chronic renal failure on cholesterol efflux and ABCA1 expression in THP-1 macrophages
17th Annual Meeting of the Austrian Atherosclerosis Society; MAI 7-8, 2010 ; St. Gilgen, Austria. 2010. [Poster]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA. [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum leptin levels and lipid profile in patients with chronic C.
17. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 7-8, 2010; St. Gilgen, AUSTRIA. 2010. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE EFFECTS OF ANTIVIRAL TREATMENT ON SERUM LEPTIN LEVELS AND LIPID PROFILE IN PATIENTS WITH CHRONIC HEPATITIS C
ATHEROSCLER SUPPL. 2010; 11(2): MS456-78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY.
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum adipokine levels and lipoproteins in patients with chronic hepatitis C.
Clin Chem Lab Med 2010; 48(10):A211-A211.-3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum adipokine levels and lipoproteins in patients with chronic hepatitis C.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Augsten, M; Scharnagl, H; Gülly, C; Ebner, B; Chemelli, A; Glatter, O; Lang, U; Desoye, G; Wadsack, C HDL: A novel fetal signal regulating placental functions.
joint zmf & doctoral day; Nov 5-6, 2009; Graz, Austria. 2009. [Oral Communication]

 

Augsten, M; Scharnagl, H; Gülly, C; Ebner, B; Chemelli, A; Glatter, O; Lang, U; Desoye, G; Wadsack, C HDL: A novel fetal signal regulating placental function.
Placenta2009; 30(9):-International Federation of Placenta Association, IFPA Meeting Placenta, the key to pregnancy success; Oct, 6-9, 2009; Adelaide, AUSTRALIA. [Poster]

 

Augsten, M; Scharnagl, H; Gülly, C; Ebner, B; Chemelli, A; Glatter, O; Mörtl, M; Lang, U; Desoye, G; Wadsack, C HDL:A novel fetal signal regulation placental functions.
Konferenzband ZMF2009; -Joint ZMF & Doctoral Days 2009; Nov, 2009; Graz, Austria. [Poster]

 

Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Fahrleitner-Pammer, A; Bohm, BO; Marz, W 25-hydroxyvitamin D levels and association with all-cause mortality in patients with type 2 diabetes mellitus
DIABETOLOGIA. 2009; 52: 316--44th General Assembly of the European Association for the Study of Diabetes (EASD); SEP 7-11, 2009; Rome, ITALY. [Poster]
Web of Science

 

Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W Influence of 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D status on serum parathyroid hormone levels varies at different levels of renal function
BONE. 2009; 44(2):S360-S360.-36th European Symposium on Calcified Tissue; MAY 23-27, 2009; Vienna, Austria. [Poster]
Web of Science FullText FullText_MUG

 

Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Böhm, B; Fahrleitner-Pammer, A; März, W Influence of 25-hydroxyvitamin D status on serum PTH levels varies with KDOQI classification of renal function and is independent of 1,25 dihydroxyvitamin D concentration
Journal of Bone and Mineral Society, Suppl.2009; -American Society for Bone and Mineral Research; SEP 11-15, 2009; Denver, USA. [Oral Communication]

 

Gary ,T; Stojakovic, T; Froehlich, H; Scharnagel, H;Hafner, F; Pilger, E; Brodmann, M Reobstruktion nach stentimplantation im Bereich der Arteria femoralis superficialis in Abhängigkeit des lp(a) Spiegels.
CD Room 2009; -115. Jahres Tagung der Deutschen Gesellschaft für Innere Medizin, DGIM; APR 18-22, 2009; Wiesbaden, Deutschland. [Poster]

 

Gary, T; Stojakovic, T; Froehlich, H; Scharnagl, H; Hafner, F; Pilger, E; Brodmann, M Association between plasma lipoprotein(a) concentration and restenosis after stent implantation in the superficial femoral artery.
Hämostaseologie-Kongressausgabe 2009; 29: 77--53. Jahrestagung der Gesellschaft für Thrombose-und Hämostaseforschung e.V. (GTH) 2009; FEB 4-7, 2009; Wien. [Poster]

 

Mullen, P; Luscher, B; Scharnagl, H; Krahenbuhl, S; Brecht, K Simvastatin Reduces Protein Prenylation and N-Linked Glycosylation But Has No Effect on Cellular Cholesterol Or Ubiquinone Content in C2C12 Myotubes
GLYCOBIOLOGY. 2009; 19(11):143--Annual Meeting of the Society for Glycobiology ; NOV 12-15, 2009; San Diego, USA. [Poster]
Web of Science

 

Putz-Bankuti, C; Stojakovic, T; Steidl, K; Scharnagl, H; Stauber, RE Turbidimetrische Messung der Hyaluronsäure im Serum bei Patienten mit Leberzirrhose.
Z Gastroenterol 2009; 47: 495-495.-42. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH) und 50. Österreichischer Chirurgenkongress; JUN 18-20, 2009; Vienna, AUSTRIA. [Poster]

 

Scharnagl, H; Stojakovic, T; Winkler, K; Seelhorst, U; Wellnitz, B; Böhm, BO; März, W; Hoffmann, MM Apolipoprotein C-III: a predictor of cardiovascular mortality? (The Ludwigshafen Risk and Cardiovascular Health Study).
16. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS). ; MAI 8-9, 2009; St.Gilgen/Wolfgangsee, AUSTRIA. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients with type 2 diabetes and/or coronary heart disease.
Clin Chem Lab Med 2009; 47(9):A47-A47.-6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL); OCT 7-10, 2009; Leipzig, GERMANY. [Poster]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, I; Schmolzer, I; Wascher, TC; Marz, W Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A20.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Steidl, K; Scharnagl, H; Stauber, RE Turbidimetric assay for measurement of hyaluronic acid in patients with liver cirrhosis.
Clin Chem Lab Med 2009; 47: S294-S294.-18th IFCC - EFCC European Congress of Clinical Chemistry and Laboratory Medicine; JUN 7-11, 2009; Innsbruck, AUSTRIA. [Poster]

 

Tomaschitz, A; Maerz, W; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Boehm, BO; Fahrleitner-Pammer, A; Wiehrauch, G; Dobnig, H Aldosterone-to-Renin Ratio Determines Peripheral and Central Blood Pressure Values Over a Broad Range and Well Below a Cut-off Suggestive of Primary Aldosteronism.
14. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; Mai 7-9, 2009 ; St.Wolfgang-Salzkammergut, Austria. 2009. [Oral Communication]

 

Weihrauch, G; Scharnagl, H; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W IL 6 is independently associated with all-cause and cardiovascular mortality.
16. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS). ; MAI 8-9, 2009; St.Gilgen/Wolfgangsee, AUSTRIA. 2009. [Poster]

 

Assadian, A; Knöbl, P; Stojakovic, T; Hübl, W; Hagmüller, GW; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Is lipoprotein(a) a useful parameter for selecting patients with asymptomatic carotid stenosis who are at risk of having a stroke?
35th Annual VEITH Symposium; NOV 19-23, 2008; New York, USA. 2008. [Oral Communication]

 

Gary, T; Stojakovic T, Froehlich H, Scharnagl H, Hafner F, Pilger E, Brodmann M; Association between Plasma Lipoprotein (a) Concentartion and Restenosis after Stent Implantation in the Superficial Femoral Artery.
vASA Supplement2008; -37.Jahrestagung der Deutschen Gesellschaft für Angiologie (DGA); SEP 24-20, 2008; Mannheim, Deutschland. [Poster]

 

Gary, T; T Stojakovic, H Froehlich, H Scharnagl, F Hafner, M Brodmann; Association Between Plasma Lipoprotein(a) Concentration and Restenosis after Stent Implantation in the Superficial Femoral Artery
AAS (Austrian Atherosclerosis Society) Jahrestagung; Apr 18-19,2008; St Gilgen, Austria. 2008. [Poster]

 

Scharnagl, H; Stojakovic, T; De Campo, A; Wascher, T; März, W The effect of fluvastatin and ezetimib on dense low density lipoproteins in patients with hypercholesterolemia and CHD.
15. Jahrestagung der Austrian Atherosclerosis Society (AAS). ; APR 18-19, 2008; St.Gilgen, AUSTRIA. 2008. [Poster]

 

Scharnagl, H; Stojakovic, T; Pittrow, D; Pieber, L; Boehler, S; Ruf, G; Maerz, W; H. Wittchen, H Association of N-terminal pro-B-type natriuretic peptide with cardiovascular risk factors: results from the DETECT study
ATHEROSCLER SUPPL 2008; 9(1):119-119.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Böhm, BO; März, W High concentration of LDL triglycerides predicts all-cause and cardiovascular mortality in individuals with coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, DEUTSCHLAND. 2008. [Poster]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
38. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 27-29, 2008; Maikammer, Deutschland. 2008. [Oral Communication]

 

Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W Effekte von Fluvastatin-Monotherapie oder in Kombination mit Ezetimibe auf LDL-Subfraktionen in einem Hochrisikokollektiv.
Wien Klin Wochenschr 2008; 120/19-20: S22-S22.-36. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 20-22, 2008; Baden, AUSTRIA. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
Z Gastroenterol. 2008; 45: 1-1.-41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); MAI 29-31, 2008; Millstatt, AUSTRIA. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Wascher, TC; März, W; Trauner, M. Improvement of dyslipidemia and vascular function in patients with cholestatic liver disease after long-term treatment with atorvastatin
Hämostaseologie. 2008; 28(1-2):A62-A62.-52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 20-23, 2008; Wiesbaden, Germany. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Wagner, M; Scharnagl, H; Wascher, TC; Marz, W; Trauner, M Long-term treatment with atorvastatin in patients with cholestatic liver disease.
ATHEROSCLER SUPPL 2008; 9(1):197-197.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Seelhorst, U; Schilling, D; Winkelmann, BR; Boehm, BO; März, W Serum gamma-glutamyl transferase predicts cardiovascular mortality in persons undergoing coronary angiography – the Ludwigshafen Risk and Cardiovascular Health Study
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; Maerz, W Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography – the Ludwigshafen Risk and Cardiovascular Health Study.
European Heart Journal 2008; 29: 592-592.-ESC Congress 2008; AUG 30 - SEP 3, 2008; Munich, GERMANY. [Poster]

 

Tomaschitz, A; Maerz, W; Pilz, S; Scharnagl, H; Renner, W; Boehm, BO; Fahrleitner-Pammer, A; Dobnig, H How does aldosterone renin ratio impact blood pressure levels? A Cross-Sectional Study of 3252 Normo- and hypertensive patients referred to coronary angiography
Endocrine Abstracts (2008) 16 P9 2008; -European Congress of Endocrinology ; 03 May 2008 - 07 May 2008; Berlin, Germany. [Poster]

 

Tomaschitz, A; März, W; Pilz, S; Scharnagl, H; Renner, W How does Aldosterone Renin Ratio Impact Blood Pressure Levels?
Journal für Klinische Endokrinologie und Stoffwechsel 2008; 1 (Sonderheft 1), 4-182008; -Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel und der Österreichischen Gesellschaft zur Erforschung des Knochens und Mineralstoffwechsels; 15. bis 17. Mai 2008; St. Wolfgang, Ö. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Maerz, W Association of cystatin C with mortality: data from the LURIC Study.
ATHEROSCLER SUPPL 2008; 9(1):78-79.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Pilz, S; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W Cystatin C and mortality in patients with cardiovascular disease - the Ludwigshafen Risk and Cardiovascular Health Study
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Pilz, S; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W Cystatin C - A marker of mortality in patients with cardiovascular disease
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008. [Poster]

 

Dobnig, H; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Riedmuller, G; Bruck, C; Tiran, B; Boehm, B; Maerz, W Serum concentrations of vitamin D are significant and independent predictors of mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
EXP CLIN ENDOCRINOL DIABETES. 115: S91-S91.-51. Annual Meeting of the German Society of Endocrinology (DGE); MAR 7-10, 2007; Salzburg, Austria. [Poster]
Web of Science

 

Scharnagl, H; Stojakovic, T; Pittrow, D; Pieber, L; Freisinger, F; Boehler, S; Ruf, G; Maerz, W; Wittchen, HU Routine care treatment of patients at high risk for cardiovascular disease in Germany: Follow-up data from the detect study
ATHEROSCLER SUPPL. 2007; 8(1):131-131.-77th Annual Congress of the European Atherosclerosis Society; JUN 10-13; Helsinki, Finland. [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Boehm, BO; März, W High concentration of LDL triglycerides predicts all-cause and cardiovascular mortality in individuals with coronary artery disease.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Boehm, BO; März, W High concentration of LDL triglycerides predicts all-cause and cardiovascular mortality in individuals with coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS); MAI 11-12, 2007; St.Gilgen, Austria. 2007. [Oral Communication]

 

Schmölzer, I; Schmut, E; de Campo, A; Sourij, H; Stojakovic, T; Scharnagl, H; Forst, T; Wascher, TC Nicht-glykämische Effekte der Insulintherapie: Ein Vergleich von Insulin Aspart und Normalinsulin während zwei aufeinanderfolgender Mahlzeiten bei Patienten mit Typ-II-Diabetes.
Abstracts zur 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):23-23.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA. [Poster]

 

Stojakovic, T; Assadian, A; Knöbl, P; Hübl, W; Senekowitsch, C; Hagmüller, GW; Eidher, U; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Low HDL cholesterol and low HDL triglycerides in patients with symptomatic and asymptomatic high grade internal carotid artery stenosis.
Journal of Thrombosis and Haemostasis 2007; 5(S2):P-W-445.-XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH); JUL 6-12, 2007; Geneva, Switzerland. [Poster]

 

Stojakovic, T; Assadian, A; Knöbl, P; Hübl, W; Senekowitsch, C; Hagmüller, GW; Eidher, U; Scharnagl, H; Winkelmann, BR; Boehm, BO; März W Prevalence of elevated lipoprotein (a) among patients with symptomatic and asymptomatic high-grade carotid artery stenosis.
Hämostaseologie. 2007; 27(1):A88-A88.-51. Jahrestagung der Gesellschaft für Thrombose- & Hämastoseforschung e.V. (GTH); FEB 21-24, 2007; Dresden, Germany. [Poster]

 

Stojakovic, T; Assadian, A; Scharnagl, H; Hübl, W; Hagmüller, GW; Winkelmann, BR; Boehm, BO; Marz, W Patients with symptomatic and asymptomatic high grade internal carotid artery stenosis have lower concentrations of high density lipoproteins.
Clin Chem Lab Med, 2007; 45(8):A129-A130.-Congress of Clinical Chemistry and Laboratory Medicine; SEP 19-22, 2007; Vienna, Austria. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Ursula Seelhorst, U; Winkelmann, BR; Boehm, BO; März W Serum gamma-glutamyltransferase, cardiovascular disease and mortality risk – the Ludwigshafen Risk and Cardiovascular Health Study.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Stojakovic, T; Scharnagl, H; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; Maerz, W Serum gamma-glutamyltransferase and cardiovascular mortality in subjects with coronary artery disease - The Ludwigshafen risk and cardiovascular health study
ATHEROSCLER SUPPL. 2007; 8(1):148-148.-77th Annual Congress of the European Atherosclerosis Society; JUN 10-13; Helsinki, Finland. [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; März, W Serum gamma-glutamyltransferase and cardiovascular mortality in subjects with coronary artery disease – the Ludwigshafen Risk and Cardiovascular Health Study.
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft – Austrian Atherosclerosis Society (AAS); MAI 11-12, 2007; St.Gilgen, Austria. 2007. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Marz, W Associations of Cystatin C with mortality data from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).
Clin Chem Lab Med, 2007; 45(8):A123-A123.-Congress of Clinical Chemistry and Laboratory Medicine; SEP 19-22, 2007; Vienna, Austria. [Poster]

 

Weihrauch, G; Dobnig, H; Scharnagl, H; Stojakovic, T; Seelhorst, U; Wellnitz, B; Winkelmann, BR; Boehm, BO; März, W Cystatin C independently associated with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Zinke-Cerwenka, W; Stojakovic, T; Schamagl, H; Wassertheurer, S; Linkesch, W Therapy response by decrease of free light chain concentration in multiple myeloma patients treated with bortezomib/doxorubicin/dexamethasone as first-line therapy
BLOOD. 2007; 110(11):278B-278B.-49th Annual Meeting of the American Society of Hematology; DEC 8-11, 2007; Atlanta, USA . [Poster]
Web of Science FullText FullText_MUG

 

Fauler, G; Stojakovic, T; Putz-Bankuti, C; Gurakuqi, GC; Scharnagl, H; Marz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
ATHEROSCLER SUPPL. 2006; 7(3):583-583.-XIV. International Symposium on Atherosclerosis; JUNE 18-22, 2006; Rome, Italy. [Poster]
Web of Science FullText FullText_MUG

 

Mangge, H; Sargsyan, K; Lang, N; Pilz, S; Horejsi, R; Moller, R; Almer, G; Windhaber, J; Schober, P; Scharnagl, H; Stojakovic, T; Marz, W The STYrian Juvenile OBesity Study (STYJOBS)
INT J OBESITY. 2006; 30: S6-S6.-16th Workshop of the European Childhood Obesity Group (ECOG) ; JUN 1-3, 2006; Rzeszów, POLAND. [Oral Communication]
Web of Science

 

Mayer, CM; Gruber, HJ; Landl, EM; Pailer, S; Scharnagl, H; Maerz, W Rosuvastatin reduces interleukin-6 induced C-reactive protein expression via STAT3 and C/EBP inhibition
ATHEROSCLER SUPPL. 7(3):570-570.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. [Poster]
Web of Science FullText FullText_MUG

 

Pilz, S; Scharnagl, H; Tiran, B; Boehm, BO; Marz, W Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease
ATHEROSCLER SUPPL. 7(3):72-72.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. [Poster]
Web of Science

 

Scharnagl, H; Meinitzer, A; Pilz, S; Stojakovic, T; Seelhorst, U; Wellnitz, B; Böhm, BO; März, W Total and cardiovascular mortality in The Ludwigshafen Risk and Cardiovascular Health Study (LURIC): Associations with adiponectin, asymetrical dimethylarginine, free fatty acids, and LDL triglycerides.
13. Jahrestagung der Austrian Atherosclerosis Society (AAS); MAI 5-6, 2006; St. Gilgen, AUSTRIA. 2006. [Oral Communication]

 

Scharnagl, H; Vogel, M; Abletshauser, C; Freisinger, F; Stojakovic, T; Maerz, W Efficacy and safety of morning administration of fluvastatin extended release formulation is equivalent to evening administration.
MED KLIN. ; 101: A109-A109.-112. Kongress der Deutschen Gesellschaft für Innere Medizin; APR 22-26, 2006; Wiesbaden, Germany. [Poster]
Web of Science

 

Scharnagl, H; Vogel, M; Abletshauser, C; Freisinger, F; Stojakovic, T; Maerz, W Efficacy and safety of morning administration of fluvastatin extended release formulation is equivalent to evening administration
ATHEROSCLER SUPPL. 7(3):576-576.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. [Poster]
Web of Science FullText FullText_MUG

 

Scharnagl, H; Vogel, M; Abletshauser, C; Freisinger, F; Stojakovic, T; März, W Efficacy and safety of morning administration of fluvastatin extended release formulation is equivalent to evening administration.
Arteriosklerose: Neue Konzepte, Risikofaktoren und Targets; Heinle H, Schulte H, von Eckardstein A (Hrsg.) 2006; 20: 207-211.-20. Jahrestagung der Deutschen Gesellschaft für Arterioskleroseforschung; März 16-18; Blaubeuren, Deutschland. (ISBN: 978-3-936423-05-1 ) [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Gurakuqi, G; Scharnagl, H; Stadlbauer, V; Stauber, R; Maerz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid.
Clin Chem Lab Med. 44(9):A207-A207.-First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC); OCT 4-7, 2006; Salzburg, Austria. [Poster]

 

Stojakovic, T; Scharnagl, H; Freisinger, F; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; Maerz, W; Wittchen, HU Prevalence of obesity and its importance to cardiovascular diseases in germany: Findings from the DETECT study
ATHEROSCLER SUPPL. 7(3):53-53.-XIV. International Symposium on Atherosclerosis; JUNE, 18-22; Rome, Italy. [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; März, W; Winkelmann, BR; Boehm, BO; Schmut O Atherogenic lipoproteins are risk factors for retinal artery occlusion or retinal vein occlusion.
36. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 30 - DEC 2, 2006; Maikammer, Deutschland. 2006. [Oral Communication]

 

Stojakovic, T; Scharnagl, H; Weger, A; Haas, A; März, W; Steinbrugger, I; Winkelmann, BR; Boehm, BO; Schmut, O Atherogenic Lipoproteins as Risk Factors for Retinal Artery Occlusion or Retinal Vein Occlusion
13. Jahrestagung der Austrian Atherosclerosis Society (AAS); MAI 5-6, 2006; St. Gilgen, AUSTRIA. 2006. [Poster]

 

Stojakovic, T; Scharnagl, H; Winkelmann, BR; Boehm, BO; März, W Elevated LDL triglycerides, but not LDL cholesterol in male patients with venous thromboembolism.
Hämostaseologie 2006; 26(1):A30-A30.-50. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 15-18, 2006; Basel, Switzerland. [Poster]

 

Winklhofer-Roob, BM; Sargsyan, K; Maritschnegg, M; Pilz, S; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W; Mangge, H Relations between antioxidants and biomarkers of consumption of fruits and vegetables and body mass index (BMI) in juvenile obesity
FREE RADICAL RES. 40: S141-S141.-13th Biennial Meeting of the Society-for-Free-Radical-Research-International; AUG 15-19; Davos, Switzerland. [Poster]
Web of Science

 

Winklhofer-Roob, M; Sargsyan, K; Maritschnegg, M; Pilz, S; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; März, W; Mangge, H Relations between antioxidants and biomarkers of consumption of fruits and vegetables and body mass index in The STYrian Juvenile OBesity Study (STYJOBS).
Austrian Atherosclerosis Society (AAS) ; Mai 5-6, 2006; St.Gilgen Wolfgangsee, Austria. 2006. [Oral Communication]

 

Bohler, S; Scharnagel, H; Freisinger, F; Stojakovic, T; Glaesmer, H; Klotsche, J; Kirch, W; Schneider, H; Stalla, G; Lehnert, H; Silber, S; Wittchen, HU; Marz, W The NCEP guidelines in a primary care sample in Germany: Degree of unmet needs: Results from the DETECT study.
EUR J CLIN PHARMACOL 2005 61: 703-703.
Web of Science

 

Gruber, HJ; Mayer, CM; Landl, EM; Panzenbock, U; Sattler, W; Scharnagl, H; Marz, W Atorvastatin induces glucose uptake via GLUT-4 in L6 skeletal muscle cells
ATHEROSCLER SUPPL. 2005; 6: 108-108.-75th Congress of the European-Atherosclerosis-Society; APR 23-26, 2005; Prague, CZECH REPUBLIC. [Poster]
Web of Science FullText FullText_MUG

 

Mangge, H; Sargsyan, K; Pilz, S; Horejsi, R; Moller, R; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W The STYrian Juvenile Obesity Study (STYJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Mayer, C; Gruber, HJ; Landl, E; Scharnagl, H; März, W STATIN INDUCED INHIBITION OF CRP EXPRESSION IN PRIMARY HUMAN HEPATOCYTES.
Atherosclerosis Supplement2005; 6: 109-109.-Congress of the European Atherosclerosis Society; April 23-26, 2005; Prague, Czech Republic. [Poster]

 

Pilz, S; Sargsyan, K; Horejsi, R; Moller, R; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W; Mangge, H Resistin correlates with low-grade inflammation, but not with preatherosclerosis and insulin resistance in obese juveniles - The STYrian Juvenile OBesity Study (STYJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Renner, W; Nauck, M; Winkelmann, BR; Hoffmann, MH; Scharnagl, H; Mayer, V; Boehm, BO; Marz, W Angiotensinogen haplotypes and angiotensinogen levels
ATHEROSCLER SUPPL 2005 6: 59-59. [Poster]
Web of Science FullText FullText_MUG

 

Sargsyan, K; Meinitzer, A; Pilz, S; Horejsi, R; Moller, R; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, S; Borkenstein, M; Marz, W; Mangge, H Serum levels of asymmetric dimethylarginine exhibit a sharp decline during adolescence, which is attenuated in obesity - The STYrian Juvenile Obesity Study (STVJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Scharnagl, H; Stojakovic, T; Winkler, K; Marz, W; Boehm, B HMG-COA reductase inhibitor cerivastatin lowers advanced glycosylation end-products in patients with type 2 diabetes
ATHEROSCLER SUPPL 2005 6: 78-78.
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005. [Oral Communication]

 

Stojakovic, T; Scharnagl, H; Freisinger, F; Tiran, A; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; Marz, W; Wittchen, HU Routine care treatment of type 2 diabetes in Germany (detect study)
ATHEROSCLER SUPPL 2005 6: 151-151.
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; Weger, M; Schmut, O; Haas, A; März, W Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion
Journal of Thrombosis and Haemostasis2005; 3(S1):P2380--XXth Congress of the International Society on Thrombosis and Haemostasis (ISTH); AUG 6-12, 2005; Sydney, Australia. [Poster]

 

Winklhofer-Roob, BM; Sargsyan, K; Maritschnegg, M; Pilz, S; Dimitrova, R; Weihrauch, G; Almer, G; Scharnagl, H; Stojakovic, T; Borkenstein, M; Marz, W; Mangge, H Relations between antioxidants and biomarkers of consumption of fruits and vegetables and body mass index in The STYrian Juvenile OBesity Study (STYJOBS)
INT J OBESITY 2005 29: -.
Web of Science

 

Gruber, H-J; Landl, E; Mayer, CM; Panzenböck, U; Sattler, W; Scharnagl, H; März, W Improved glucose uptake in L6 cells by HMG-CoA reductase inhibition
Jahrestagung2004; -34. Jahrestagung des Arbeitskreises Klinischer Lipidstoffwechsel; NOV 25, 2004; Maikammer, GERMANY. [Oral Communication]

 

Gruber, HJ; Mayer, C; Landl, E;Panzenböck, U; Sattler, W; Scharnagl, H; März, W IMPAIRED GLUCOSE UPTAKE IN L6 CELLS BY HMG-CO-A-REDUCTASE INHIBITION.
XV Symposium on Drugs Affecting Lipid Metabolism.; October 24-27, 2004; Venice, Italy. 2004. [Poster]

 

Khuseyinova, N; Imhof, A; Rothenbacher, D; Trischler, G; Scharnagl, H; Maerz, W; Brenner, H; Koenig, W Association between lipoprotein-associated phospholipase A2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
CIRCULATION 2004 110: 775-775.
Web of Science

 

Khuseyinova, N; Imhof, A; Rothenbacher, D; Trischler, G; Scharnagl, H; Maerz, W; Brenner, H; Koenig, W Association between lipoprotein-associated phospholipase A2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis
EUR HEART J 2004 25: 443-443.
Web of Science

 

Maerz, W; Scharnagl, H; Winkler, K; Tiran, A; Nauck, M; Boehm, BO; Winkelmann, BR Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary disease(The Ludwigshafen risk and cardiovascular health study)
CIRCULATION 2004 110: 118-118.
Web of Science

 

Marz, W; Scharnagl, H; Nauck, M; Bohm, B; Winkelman, B The apolipoprotein E polymorphism is associated with circulating C-reactive protein (The Ludwigshafen Risk and Cardiovascular Health Study)
ATHEROSCLER SUPPL 2004 5: 87-87.
Web of Science

 

Marz, W; Scharnagl, H; Nauck, M; Tiran, A; Bohm, B; Winkelmann, B Low density lipoprotein triglycerides assuciated with low grade systemic inflammation, adhesion molecules and stable angiographic coronary disease
ATHEROSCLER SUPPL 2004 5: 12-12.
Web of Science

 

Mayer, C; Gruber, HJ; Landl, E; Scharnagl, H; März, W EFFECT OF HMG-CoA REDUCTASE INHIBITION ON CRP EXPRESSION IN PRIMARY HUMAN HEPATOCYTES.
XV Symposium on Drugs Affecting Lipid Metabolism.; October 24-27, 2004; Venice, ITALY. 2004. [Poster]

 

Renner, W; Hoffmann, M; Winkelmann, B; Scharnagl, H; Bohm, B; Marz, W The P12A polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene associated premature coronary heart disease and myocardial infraction. (The Ludwigshafen Risk and Cardiovascular Health Study)
ATHEROSCLER SUPPL 2004 5: 89-89.
Web of Science

 

Scharnagl, H; Freisinger, F; Tiran, A; Stojakovic, T; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; März, W; Wittchen, H The gap between treatment guidelines and routine care treatment patters in the management of high risk patients: Findings from the detect study
ATHEROSCLER SUPPL. ATHEROSCLER SUPPL2004; 5: 150-150.-74th Congress of the European-Atherosclerosis-Society; APR 17, 2004; Seville, SPAIN.
Web of Science

 

Stojakovic, T; Scharnagl, H; Freisinger, F; Tiran, A; Pittrow, D; Glaesmer, H; Boehler, S; Ruf, G; März, W; Wittchen, HU The gap between treatment guidelines and routine care treatment patterns in the management of high risk patients: findings from the DETECT study.
34. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2004; Maikammer, Deutschland. 2004. [Oral Communication]

 

Scharnagl, H; Kist, M; Grawitz, AB; Koenig, W; Wieland, H; März, W Helicobacter pylori eradication increases high density lipoproteins
ATHEROSCLER SUPPL 2003 4: 73-73.
Web of Science FullText FullText_MUG

 

Scharnagl, H; Winkler, K; Nauck, MA; Boehm, BO; Winkelmann, BR; März, W Low density lipoprotein triglycerides are associated with low grade systemic inflammation, adhesion molecules and angiographic coronary artery disease.
33. Jahrestagung des Arbeistkreieses Lipidstoffwechsel; NOV, 27-29, 2003; Maikammer, Germany. 2003. [Oral Communication]

 

Spaniol, M; Kaufmann, P; Beier, K; Wuethrich, J; Scharnagl, H; Maerz, W; Kraehenbuehl, S Mechanism of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate
J HEPATOL 2002 36: 23-23.
Web of Science FullText FullText_MUG

 

Imhof, A; Rothenbacher, D; Hoffmeister, A; Brenner, H; Maerz, W; Nauck, M; Scharnagl, H; Koenig, W Plasma lipoprotein(a) levels are independently associated with chronic coronary artery disease: results of a large case-control study
EUR HEART J 2000 21: 628-628.
Web of Science

 

Scharnagl, H; Tisljar, U; Gierens, H; Wieland, H; Marz, W Effect of pravastatin on endothelial NO-synthesis in comparison to other HMG-CoA-reductase inhibitors
ATHEROSCLEROSIS 1999 144: 29-29.
Web of Science FullText FullText_MUG

 

Schlemmer, E; Hoffmann, MM; Scharnagl, H; Neuhaus, G; Wieland, H; Marz, W Expression and functional characterization of the extracellular domain II of the LDL receptor related protein
ATHEROSCLEROSIS 1999 144: 111-111.
Web of Science FullText FullText_MUG

 

Gierens, H; Nauck, MS; Roth, M; Schinker, R; Scharnagl, H; Wieland, H; Maerz, W Interleukin 6 stimulates the expression of LDL receptors via the cis-acting sterol-responsive element (SRE)
CIRCULATION 1998 98: 107-107.
Web of Science

 

Marz, W; Scharnagl, H; Abletshauser, C; Wieland, H; Baumstark, M Effect of fluvastatin on small dense low density lipoproteins in postmenopausal women with an atherogenic lipoprotein phenotype
ATHEROSCLEROSIS 1997 134: 129-129.
Web of Science FullText FullText_MUG

 

Marz, W; Scharnagl, H; Winkler, K; Gierens, H; Nauck, M; Hoffmann, M; Klima, B; Schliack, M; Loser, R; Lang, G; Gross, W; Wieland, H Lifibrol (K12.148): First member of a new class of hypolipidemic drugs?
ATHEROSCLEROSIS 1997 130: 18-18.
Web of Science

 

Nauck, M; Scharnagl, H; Koster, W; Nissen, H; Marz, W; Wieland, H Mutations in the genes encoding the low-density lipoprotein receptor and apolipoprotein B in Southwest Germany
ATHEROSCLEROSIS 1997 134: 70-71.
Web of Science FullText FullText_MUG

 

Scharnagl, H; Feussner, G; Acar, J; Wieland, H; Marz, W Apolipoprotein E deficient remnant lipoproteins and recombinant apolipoprotein E: A new model to characterize the interaction of apolipoprotein E with lipoprotein receptors and proteoglycans
ATHEROSCLEROSIS 1997 134: 361-361.
Web of Science FullText FullText_MUG

 

Winkler, K; Schafer, J; Klima, B; Scharnagl, H; Nuber, C; Grathwohl, D; Koster, W; Wieland, H; Marz, W Influence of lifibrol therapy on apoB metabolism in mired hyperlipidemia and hypercholesterolemic patients
ATHEROSCLEROSIS 1997 134: 135-135.
Web of Science FullText FullText_MUG

 

Winkler, K; Scharnagl, H; Hoschutzky, B; Hoffmann, MM; Friedrich, I; Wieland, H; Marz, W Apolipoprotein E and beta-A4 amyloid are immunologically and functionally related
ATHEROSCLEROSIS 1997 134: 21-21.
Web of Science FullText FullText_MUG

 

Schaefer, JR; Scharnagel, H; Baumstark, M; Schweer, H; Winkler, K; Maisch, B; Steinmetz, A; Maerz, W Increased in vivo HDL-ApoA-I production in homozygous familial defective apolipoprotein B-100.
CIRCULATION 1996 94: 3414-3414.
Web of Science

 

MONDORF, UF; SIEKMEIER, R; MARZ, U; SCHARNAGL, H; GROSS, W; SCHOEPPE, W CHOLESTEROL LOADING OF RAT MESANGIAL CELLS LEADS TO INCREASED DEGRADATION OF LIPOPROTEIN(A)
KIDNEY INT. 47: 989-989.
Web of Science

 

© Med Uni Graz Impressum